Literature DB >> 1701228

Distribution and actions of galanin and vasoactive intestinal peptide in the human colon.

D E Burleigh1, J B Furness.   

Abstract

Responses to galanin (GAL) and vasoactive intestinal peptide (VIP) and their distribution were investigated in muscularis externa from the human sigmoid colon. Immunohistochemical studies revealed GAL-like immunoreactivity (GAL-IR) and VIP-IR in nerve fibres supplying both muscle layers as well as the myenteric ganglia. Additionally GAL-IR was shown to co-exist with VIP-IR in many nerve fibres innervating human circular and longitudinal (taenial) colonic muscle layers. Circular and longitudinal muscle strips were contracted by GAL and relaxed by VIP. There was a marked difference in sensitivity between muscle layers to both peptides; circular muscle being less sensitive to GAL, longitudinal muscle less sensitive to VIP. When given simultaneously GAL attenuated responses to VIP on longitudinal muscle, thus in the same neurone there are substances having opposing actions on smooth muscle motility.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701228     DOI: 10.1016/0143-4179(90)90115-f

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  5 in total

1.  Cholinergic and nitrergic interneurones in the myenteric plexus of the human colon.

Authors:  A J Porter; D A Wattchow; S J H Brookes; M Costa
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 2.  Galanin.

Authors:  M E Vrontakis; A Torsello; H G Friesen
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

3.  Vasoactive intestinal polypeptide and nitric oxide synthase distribution in the enteric plexuses of the human colon: an histochemical study and quantitative analysis.

Authors:  P Matini; M S Faussone-Pellegrini; C Cortesini; B Mayer
Journal:  Histochem Cell Biol       Date:  1995-06       Impact factor: 4.304

4.  Galanin plays an important role in cancer invasiveness and is associated with poor prognosis in stage II colorectal cancer.

Authors:  Kinuko Nagayoshi; Takashi Ueki; Kosuke Tashiro; Yusuke Mizuuchi; Tatsuya Manabe; Hiromitsu Araki; Yoshinao Oda; Satoru Kuhara; Masao Tanaka
Journal:  Oncol Rep       Date:  2014-12-09       Impact factor: 3.906

5.  Colorectal cancer patients exhibit increased levels of galanin in serum and colon tissues.

Authors:  Przemysław Kwiatkowski; Janusz Godlewski; Jacek Kieżun; Bartłomiej Emil Kraziński; Zbigniew Kmieć
Journal:  Oncol Lett       Date:  2016-08-23       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.